Induction of tumor necrosis factor α and interleukin-1β in subcutaneously implanted chamber by lipopolysaccharide

Lipopolysaccharide (LPS) is the major component of the outermost membrane of Gram-negative bacteria and is considered to be one of the major virulence factors of these bacteria. While the effect of systemic injection of LPS is well characterized, the characterization of cytokine secretion in response to local injection of LPS is lacking. The present study was designed to determine the local production of tumor necrosis factor α (TNFα) and interleukin-1β (IL-1β) over a 4 day period following injection of LPS into subcutaneous implanted chambers in mice. Mice were challenged by a single or repeated injection of Salmonella typhosa LPS into the chambers. Chamber fluids were aspirated at different time intervals and were used for assessment of leukocyte and cytokine levels. A single injection of LPS was found to induce cell influx into the chamber which peaked after 4 h. TNFα and IL-1β levels increased rapidly, reaching their maximum levels within 4 h. After 24 h, TNFα levels declined markedly and were undetectable at 48 and 96 h. TNFα mRNA levels in the sedimented cells followed a similar pattern. In contrast, IL-1β showed a more gradual decrease with levels significantly different from baseline still being present 96 h post-LPS challenge. Four consecutive daily injections of LPS into the chambers resulted in undetectable levels of TNFα in the chamber fluid, while significant levels of IL-1β were detected. These levels were significantly higher than the levels of IL-1β in the chamber fluid 96 h after a single injection and approximately 60% of the levels measured 24 h after a single intra-chamber injection of LPS. The results emphasize the difference between single and repeated exposure to LPS in vivo, and suggest a role for TNFα in the initial phase of the local inflammatory response and for IL-1β in the later phase.

[1]  M. Plauth,et al.  Mechanism of endotoxin tolerance in patients with liver cirrhosis: Counterregulation by antiinflammatory mediators and target cell desensitization , 1998 .

[2]  K. Matsushima,et al.  Intervention in endotoxin shock by sulfatide (I3SO3-GalCer) with a concomitant reduction in tumor necrosis factor alpha production , 1997, Infection and immunity.

[3]  L. Shapira,et al.  Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion , 1996, Infection and immunity.

[4]  R. Darveau,et al.  Porphyromonas gingivalis lipopolysaccharide is poorly recognized by molecular components of innate host defense in a mouse model of early inflammation , 1995, Infection and immunity.

[5]  H. Redl,et al.  Similar cytokine but different coagulation responses to lipopolysaccharide injection in D-galactosamine-sensitized versus nonsensitized rats , 1994, Infection and immunity.

[6]  C. Genco,et al.  Animal chamber models for study of host-parasite interactions. , 1994, Methods in enzymology.

[7]  W. Buurman,et al.  Interleukin-8 release in baboon septicemia is partially dependent on tumor necrosis factor. , 1993, The Journal of infectious diseases.

[8]  G. D. Martich,et al.  Response of man to endotoxin. , 1993, Immunobiology.

[9]  P. Heinrich,et al.  Time course of various inflammatory mediators during recurrent endotoxemia. , 1992, Biochemical pharmacology.

[10]  S. Socransky,et al.  Tissue levels of bone resorptive cytokines in periodontal disease. , 1991, Journal of periodontology.

[11]  G. Mundy,et al.  Inflammatory mediators and the destruction of bone. , 1991, Journal of periodontal research.

[12]  R. Danner,et al.  Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents , 1991, The Journal of experimental medicine.

[13]  D. Remick,et al.  In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. , 1991, The American journal of pathology.

[14]  T. Mózes,et al.  Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock. , 1991, Immunology letters.

[15]  R. Strieter,et al.  Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations. , 1990, The American journal of pathology.

[16]  R. Strieter,et al.  Role of tumor necrosis factor-α in lipopolysaccharide-induced pathologic alterations , 1990 .

[17]  J. Kovacs,et al.  The cardiovascular response of normal humans to the administration of endotoxin. , 1989, The New England journal of medicine.

[18]  J. Papadimitriou,et al.  Macrophages: current views on their differentiation, structure, and function. , 1989, Ultrastructural pathology.

[19]  A. Cerami,et al.  Detection of circulating tumor necrosis factor after endotoxin administration. , 1988, The New England journal of medicine.

[20]  K. Tracey,et al.  Cytokine appearance in human endotoxemia and primate bacteremia. , 1988, Surgery, gynecology & obstetrics.

[21]  M. Wilson,et al.  Lipopolysaccharide (endotoxin) from individual periodontally involved teeth. , 1987, Journal of clinical periodontology.

[22]  F. Bauss,et al.  Tumor necrosis factor mediates endotoxic effects in mice , 1987, Infection and immunity.

[23]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[24]  C. Nathan,et al.  Secretory products of macrophages. , 1987, The Journal of clinical investigation.

[25]  D. Morrison,et al.  Endotoxins and disease mechanisms. , 1987, Annual review of medicine.

[26]  M. Wilson,et al.  Identity of limulus amoebocyte lysate-active root surface materials from periodontally involved teeth. , 1986, Journal of clinical periodontology.

[27]  L. Tabak,et al.  Preliminary characterization of material eluted from the roots of periodontally diseased teeth. , 1980, Journal of periodontal research.